2024/11/01 08:02:46 | |
---|---|
Price | |
8.339 EUR | |
Difference | 11.19% (0.84) |
ISIN | CA0717341071 |
Symbol | BHC |
Exchange | Munich |
Currency | EUR |
Sector | Other |
Security type | Stock |
Market cap (m) | 3,103 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | 8.337 EUR (500) |
Ask (Ask size) | 8.579 EUR (500) |
Open | 8.339 EUR |
High | 8.339 EUR |
Low | 8.339 EUR |
Close (prev. day) | 7.50 EUR |
VWAP | 5.67 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2024/11/01 08:02:46 | |
---|---|
Price | |
8.339 EUR | |
Difference | 11.19% (0.84) |
ISIN | CA0717341071 |
Symbol | BHC |
Exchange | Munich |
Currency | EUR |
Sector | Other |
Security type | Stock |
Market cap (m) | 3,103 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | 8.337 EUR (500) |
Ask (Ask size) | 8.579 EUR (500) |
Open | 8.339 EUR |
High | 8.339 EUR |
Low | 8.339 EUR |
Close (prev. day) | 7.50 EUR |
VWAP | 5.67 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6M | 1Y | 3Y | |
Perf (%) | -8.66% | +19.07% | -68.51% |
Perf (abs.) | -0.71 | +1.20 | -16.32 |
Beta | 1.02 | 1.45 | 1.73 |
Volatility | 41.47 | 36.42 | 60.45 |
Ø price 5 days | Ø volume 5 days (pcs.) | 7.494 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 7.416 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 6.305 EUR (21) |
Ø price 250 days | Ø volume 250 days (pcs.) | 6.952 EUR (10) |
YTD High | date | 9.800 EUR (2024/04/02) |
YTD Low | date | 4.848 EUR (2024/08/08) |
52 Weeks High | date | 9.800 EUR (2024/04/02) |
52 Weeks Low | date | 4.848 EUR (2024/08/08) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/31 | 22:26 | 8.406 EUR | 0.02 | 2 |
Toronto Stock Exchange | 2024/10/31 | 21:00 | 12.81 CAD | 7.77 | 2,253 |
Stuttgart | 2024/11/01 | 08:00 | 8.377 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2019/06/28 | 17:35 | 24.11 CHF | 0.00 | 1 |
NYSE | 2024/10/31 | 21:00 | 9.20 USD | 69.55 | 41,187 |
Munich | 2024/11/01 | 08:02 | 8.339 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:09 | 8.383 EUR | 0.00 | 1 |
Duesseldorf | 2024/11/01 | 08:10 | 8.321 EUR | 0.00 | 1 |
Berlin | 2024/11/01 | 08:02 | 8.344 EUR | 0.00 | 1 |
BAUSCH HEALTH COS. INC. |
- - |
2150 St. Elzéar Boulevard West - H7L 4A8 Laval |
Telefon: +1-514-744-6792 |
Fax: + |
E-mail: - |
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada. |
Thomas Appio | Chairman of Managing Board |
Aimee Lenar | Member of Executive Committee |
Cees Heiman | Member of Executive Committee |
Donald Pearl | Member of Executive Committee |
Fernando Zarate | Member of Executive Committee |
Jean-Jacques Charhon | Member of Executive Committee |
Jiny Kim | Member of Executive Committee |
Kathleen Fitzpatrick | Member of Executive Committee |
Mirza Dautbegovic | Member of Executive Committee |
Seana Carson | Member of Executive Committee |
John Paulson | Chairman of Supervisory Board |
Amy Wechsler | Member of Supervisory Board |
Richard Mulligan | Member of Supervisory Board |
Brett Icahn | Member of Supervisory Board |
Christian Garcia | Member of Supervisory Board |
Frank Lee | Member of Supervisory Board |
Robert Power | Member of Supervisory Board |
Sarah Kavanagh | Member of Supervisory Board |
Steven Miller | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.